Pfizer Inc. · PFE · Next earnings

Pfizer Inc. reports Tuesday, Feb 2, 2027

PFE reports before market open with consensus EPS at $0.72 and revenue at $16.89B. Last quarter: Pfizer raises 2026 revenue outlook as acquired portfolio expands

Reports Before market open90 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $0.72 Calendar consensus
Consensus revenue $16.89B Calendar consensus
Report date Feb 2, 2027 Tuesday, date estimated
Session Before market open 90 days away

Where PFE left off: FY2026 Q3

Full report

Pfizer raises 2026 revenue outlook as acquired portfolio expands

EPS surprise +18.4% Reported $0.87 vs $0.73
Revenue surprise +4.6% Reported $16.58B vs $15.85B
Stock move -2.2% Event window
Subsequent drift 0.0% Up to 20 sessions

Full-year 2026 revenue guidance was raised by $1.5 billion; the adjusted EPS outlook range was narrowed. The supplied analysis does not specify the revised endpoints.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Loss of exclusivity for products including Eliquis, Ibrance, and Xtandi could pressure legacy revenue.
  • Potential MFN, IRA, and 340B policy or pricing changes could affect U.S. net prices.
  • Pipeline, regulatory, and global launch execution remain uncertain.
  • Competition in oncology, migraine, and obesity markets may challenge commercial growth.

Questions analysts left open

  • Gross-to-net pricing dynamics and the effect of 340B on U.S. net price.
  • Timing and impact of loss of exclusivity on legacy revenue streams.
  • Readout timing for tilrekimig, MEVPRO, and berobenatide studies.
  • Potential MFN and IRA pricing changes and competitive positioning in obesity and migraine.

Ask FN2 about PFE next report

Transcript, numbers and history already loaded
What should I watch for in PFE's next earnings report?How did PFE guide last quarter, and is consensus above or below that?Give me the bull and bear case going into PFE earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the PFE recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent PFE quarters

All PFE earnings
-2.2%FY2026 Q3+1.5%FY2026 Q2+0.6%FY2026 Q1-3.3%FY2025 Q4

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.